Enfermedades retinianas y nuevas terapias
University Hospital Heidelberg
Heidelberg, AlemaniaPublicaciones en colaboración con investigadores/as de University Hospital Heidelberg (1)
2018
-
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials
JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677